{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-112570","form_type":"8-K","ticker":"CYTK","cik":"0001061983","company_name":"CYTOKINETICS INC","filed_at":"2025-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.229134+00:00","generated_at":"2026-05-17T08:26:25.201871+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cytokinetics presents new aficamten data at ESC 2025; shows improvement vs metoprolol","bullets":["MAPLE-HCM: aficamten superior to metoprolol on diastolic function, SAM, and LVOT obstruction (p<0.001); reduced max wall thickness (-1.01mm, p=0.015).","Atrial fibrillation annual incidence with aficamten was 1.5%, consistent with predicted HCM-AF and CHARGE-AF rates; minimal clinical impact.","Integrated safety of 463 patients (~700 patient-years) shows similar AE profile to placebo; low LVEF<50% incidence, no permanent discontinuations.","Longer-term FOREST-HCM: 69% and 93% of patients improved NYHA class at Week 12 and 96; KCCQ-CSS +15 and +16.","FDA NDA under review with PDUFA target action date of December 26, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-112570","json":"https://secwatch.observer/filing/0000950170-25-112570.json","markdown":"https://secwatch.observer/filing/0000950170-25-112570.md","text":"https://secwatch.observer/filing/0000950170-25-112570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1061983/000095017025112570/0000950170-25-112570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1061983/000095017025112570/cytk-20250831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:26:25.201871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001193125-26-251791","ticker":"KRMN","company_name":"Karman Holdings Inc.","filed_at":"2026-06-01T21:28:29+00:00","headline":"Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds","event_type":"other_material","sec_items":["1.01","7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251791","json":"https://secwatch.observer/filing/0001193125-26-251791.json","markdown":"https://secwatch.observer/filing/0001193125-26-251791.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2040127/000119312526251791/0001193125-26-251791-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2040127/000119312526251791/d117104d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026668","ticker":"PECE","company_name":"Peace Acquisition Corp.","filed_at":"2026-06-01T21:16:08+00:00","headline":"Peace Acquisition Corp closes IPO of 6M units at $10.00/unit, raising $60M","event_type":"other_material","sec_items":["3.02","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026668","json":"https://secwatch.observer/filing/0001493152-26-026668.json","markdown":"https://secwatch.observer/filing/0001493152-26-026668.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2088626/000149315226026668/0001493152-26-026668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2088626/000149315226026668/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026656","ticker":"MVIS","company_name":"MICROVISION, INC.","filed_at":"2026-06-01T21:02:36+00:00","headline":"MicroVision seeks reverse stock split approval; ratio 1:5 to 1:15; annual meeting July 10, 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026656","json":"https://secwatch.observer/filing/0001493152-26-026656.json","markdown":"https://secwatch.observer/filing/0001493152-26-026656.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/65770/000149315226026656/0001493152-26-026656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/65770/000149315226026656/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026649","ticker":"VDTA","company_name":"Vertical Data Inc.","filed_at":"2026-06-01T20:47:23+00:00","headline":"Vertical Data launches Vertical Edge, a direct-ownership edge data center platform","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026649","json":"https://secwatch.observer/filing/0001493152-26-026649.json","markdown":"https://secwatch.observer/filing/0001493152-26-026649.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2033264/000149315226026649/0001493152-26-026649-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2033264/000149315226026649/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026638","ticker":"XAIR","company_name":"Beyond Air, Inc.","filed_at":"2026-06-01T20:30:41+00:00","headline":"Beyond Air receives Nasdaq panel grant for continued listing; must meet bid price rule by July 31, 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026638","json":"https://secwatch.observer/filing/0001493152-26-026638.json","markdown":"https://secwatch.observer/filing/0001493152-26-026638.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315226026638/0001493152-26-026638-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315226026638/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0000798359-26-000057","ticker":"CSR","company_name":"CENTERSPACE","filed_at":"2026-06-01T20:30:13+00:00","headline":"Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000798359-26-000057","json":"https://secwatch.observer/filing/0000798359-26-000057.json","markdown":"https://secwatch.observer/filing/0000798359-26-000057.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/798359/000079835926000057/0000798359-26-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/798359/000079835926000057/iret-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251399","ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2026-06-01T20:05:32+00:00","headline":"IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251399","json":"https://secwatch.observer/filing/0001193125-26-251399.json","markdown":"https://secwatch.observer/filing/0001193125-26-251399.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526251399/0001193125-26-251399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526251399/d138848d8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}